4 - T-Cell Redirecting Bispecific Antibodies in the Treatment of Multiple Myeloma: The Utility of Disease Biomarkers in Optimizing the Treatment Benefits
Industry Theater Sponsor Presentation: MIDD Strategies for Preclinical and Clinical Translation & A Comprehensive Solution Designed to Reduce Reliance on Animal Testing, Presented by Certara